Olon Ricerca Bioscience

Olon Ricerca bioscience has adopted the Vision of Olon Group: Visit our official website

Olon Group is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO Partners and Generics.

We provide an integrated package of chemical synthesis and biological processing services on which clients rely on to manage their drug manufacturing projects, in strict compliant with regulations.

Olon Group relies on a network of manufacturing plants across the globe and on several decades of experience in supporting pharmaceutical, biotech, food, chemical and bio-industrial companies.

Thanks to 2.300 employees and 200 highly experienced and qualified people in R&D team, we are a highly reliable partner. In Olon, expertise and competence are combined with great flexibility at different levels, namely in the field of microbial fermentation processes – always considering human safety and environmental security.

Our mission is to promote science and lead innovation in the chemical sector thanks to creative and sustainable ideas and pathways. Olon challenges and innovates the way to deliver science in order to improve human health.

Change/Challenge and innovate the way to deliver science to improve health of all human beings

Being part of the Olon CDMO Division, Olon Ricerca Bioscience is following the Five Strong Pillars concept, to ensure that the company consistently meet or exceed customers’ expectations.

Our Vision

Excellent customer service requires an in-depth understanding of the customer’s needs. Across the Olon Group, flexibility is also essential because projects may be initiated at any of our sites but require support from different or multiple locations.

Cooperation is therefore also fundamental to achieving QOTIF. Having the same quality system across the entire group provides assurance to our customers that their products will be produced to the same exacting standards throughout the lifetime of each project.

Olon Group, as a whole, has the ability to support customers from early-phase development to commercial production and to produce milligrams to tons of material. These capabilities are backed by the strong financial stability of the company. We are also interested in being strategic partners with our customers and are committed to forming long-term, risk-sharing, win-win relationships.

Our management approach involves the use of dedicated project teams that support each project from start to finish. This approach allows for excellent communication and the building of strong relationships between Olon Ricerca Bioscience scientists and our clients. We have, in fact, had many customers that bring us repeat business, where clients specifically request the same project teams.

At Olon, we take this issue seriously and have procedures in place to ensure that security is maintained at all times. In addition, we cooperate with our customers to ensure that appropriate measures are implemented to protect their information.

Cost management is always an issue for any business and it is of particular concern today for the pharmaceutical industry. Because Olon is involved in the generics market, where competition is largely based on pricing, we have gained experience in achieving cost-effective production methods. This experience is then applied to projects implemented by our CRO/CDMO businesses to the benefit of our customers.

THE FIVE STRONG PILLARS INCLUDE:

• Quality On Time In Full (QOTIF)
• Supporting customers from R&D to commercial quantities
• A strong team-based project management culture
• Security of project information
• Cost management